EPHX2 rs324650: What Your Genotype Means
The rs324650 variant is a non-synonymous genetic change located within the EPHX2 gene. It has been studied for its potential role in influencing cardiovascular metabolic processes and susceptibility to ischemic stroke.
What each genotype means
Typical EPHX2 activity
This genotype represents the most common form of the EPHX2 gene in many populations. Research into this variant is ongoing, and current evidence regarding its specific impact on cardiovascular or metabolic health remains limited and inconclusive.
This is the most frequent genotype in many global populations, though exact percentages vary by ancestry.
Common genetic variation
You carry one copy of the variant allele associated with the EPHX2 gene. While this gene is involved in regulating cardiovascular metabolic tone, current scientific literature does not provide a definitive clinical interpretation for this specific genotype.
This heterozygous genotype is observed at moderate frequencies in European and East Asian cohorts.
Variant EPHX2 profile
You carry two copies of the variant allele for this EPHX2 marker. While some studies have explored the role of EPHX2 in ischemic stroke susceptibility and metabolic health, the evidence linking this specific genotype to clinical outcomes is limited and not currently used for diagnostic purposes.
This genotype is less common than the homozygous reference, appearing in approximately 20-25% of individuals in certain European and East Asian populations.
Understanding the rs324650 Variant
The rs324650 variant is a single nucleotide polymorphism (SNP) located within the EPHX2 gene, which encodes the enzyme soluble epoxide hydrolase (sEH). In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is classified as non-synonymous, meaning the change in the DNA sequence results in a different amino acid being incorporated into the protein structure. Because proteins are the functional building blocks of the body, alterations in their sequence can potentially change how they interact with other molecules or how efficiently they perform their biological tasks. Researchers study these variants to understand how subtle differences in our genetic code contribute to the diversity of human health and disease risk.
The Role of the EPHX2 Gene
The EPHX2 gene provides instructions for making the soluble epoxide hydrolase enzyme. This enzyme plays a critical role in the metabolism of epoxyeicosatrienoic acids (EETs), which are signaling molecules derived from polyunsaturated fatty acids. EETs are known to have protective effects on the cardiovascular system, including promoting the relaxation of blood vessels, reducing inflammation, and preventing the formation of blood clots. By breaking down these beneficial molecules, the sEH enzyme effectively limits their availability in the body. Consequently, variations in the EPHX2 gene that alter the activity or stability of this enzyme may influence the balance of these signaling molecules, potentially impacting cardiovascular health, blood pressure regulation, and the body's response to vascular stress.
Research Associations and Evidence Strength
Scientific research has investigated the link between EPHX2 variants and various cardiovascular conditions, including hypertension, coronary artery disease, and ischemic stroke. Studies have suggested that certain genetic profiles in EPHX2 may be associated with altered enzyme activity, which in turn could influence stroke risk. However, it is important to note that the evidence strength for rs324650 specifically is currently considered limited. While some studies have observed statistical associations in specific cohorts, these findings are not always consistent across different populations or study designs. Genetic associations are complex, and cardiovascular health is influenced by a wide array of factors, including diet, lifestyle, environment, and the cumulative effect of many other genetic variants. Therefore, this variant should be viewed as one small piece of a much larger, ongoing puzzle in cardiovascular genetics.
Population Frequency
The rs324650 variant is found at varying frequencies across different global populations. Current data indicates a minor allele frequency of approximately 20-25% in European and East Asian cohorts. This means that a significant portion of the population carries at least one copy of the variant allele. Because the frequency is relatively high, it is considered a common variant rather than a rare mutation. Understanding these frequencies is essential for researchers when designing studies to ensure that findings are representative of diverse groups. However, frequency alone does not determine the clinical significance of a variant, and researchers continue to analyze how these common variations interact with other genetic and environmental factors to influence health outcomes across different ancestral backgrounds.
Interpreting Your Genetic Information
If you have received information about your rs324650 genotype, it is important to understand that this data is for educational purposes and does not constitute a medical diagnosis. Genetic variants are statistical markers, not deterministic predictors of health. Having a specific genotype does not mean you will develop a particular condition, nor does it guarantee protection from one. Cardiovascular health is determined by a complex interplay of genetics, environment, and personal health history. If you are concerned about your cardiovascular risk or have questions about how your genetic profile might relate to your health, you should discuss this information with a qualified healthcare provider or a genetic counselor. They can help you interpret these results in the context of your overall health and provide guidance on appropriate screening or lifestyle adjustments.
How common is this variant?
The rs324650 variant is common, with a minor allele frequency of approximately 20-25% in European and East Asian cohorts.
Frequently asked questions
Does having the rs324650 variant mean I will have a stroke?
No. Genetic variants like rs324650 are associated with statistical differences in risk, not certainty. Many factors, including lifestyle, diet, and other genetic markers, play a much larger role in determining your actual health outcomes.
Can I use this information to change my medication?
You should never change or stop any medication based on genetic test results without consulting your doctor. Always discuss your genetic information with a healthcare professional or pharmacist who can provide guidance based on your full medical history.
Is rs324650 the only gene related to stroke risk?
Absolutely not. Stroke risk is polygenic, meaning it is influenced by hundreds of different genetic variants across the entire genome. Additionally, non-genetic factors like blood pressure, smoking, and physical activity are major contributors to stroke risk.
Where can I find more reliable information about EPHX2?
You can find reliable information through resources like MedlinePlus Genetics, the GWAS Catalog, and peer-reviewed journals indexed on PubMed. These sources provide evidence-based summaries of how specific genes and variants relate to human health.
Sources & further reading
Educational information only, last refreshed 9/29/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs324650?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29